FindTrial
Sign In

Prospective, Single-blinded and Split Lesion Randomized Comparative Study between Q-switched 532nm, Q-switched 755nm and Picosecond 755nm Lasers in Treatment of Cafe-au-lait Macules

Prospective, Single-blinded and Split Lesion Randomized Comparative Study between Q-switched 532nm, Q-switched 755nm and Picosecond 755nm Lasers in Treatment of Cafe-au-lait Macules

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014271
Enrollment
Unknown
Registered
2018-01-02
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cafe-au-lait Macules

Interventions

QS532nm group:QS532nm treatment
QS755nm group:QS755nm treatment
Picosecond755nm group:Picosecond755nm treatment

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 60 Years

Inclusion criteria

Inclusion criteria: meet the diagnostic criteria of cafe-au-lait macules; never receive any tratments before; signature the informed consent

Exclusion criteria

Exclusion criteria: neurofibromatosis type 1; pregnant; allergic to topical anesthesia; wound in the macules; participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS;—

Countries

China

Contacts

Public ContactGu Yifei

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

dr.guyifei@outlook.com+86 17717547327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026